PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 175 filers reported holding PRECIGEN INC in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $105,206 | +40.0% | 74,089 | +13.4% | 0.00% | – |
| Q2 2023 | $75,125 | +46.1% | 65,326 | +34.7% | 0.00% | – |
| Q1 2023 | $51,403 | -32.1% | 48,493 | -2.7% | 0.00% | – |
| Q4 2022 | $75,728 | -5.3% | 49,821 | +32.0% | 0.00% | – |
| Q3 2022 | $80,000 | +53.8% | 37,736 | -2.0% | 0.00% | – |
| Q2 2022 | $52,000 | -37.3% | 38,517 | -2.3% | 0.00% | – |
| Q1 2022 | $83,000 | -43.5% | 39,429 | -0.6% | 0.00% | – |
| Q4 2021 | $147,000 | -50.2% | 39,674 | -32.9% | 0.00% | – |
| Q3 2021 | $295,000 | -26.6% | 59,140 | -4.2% | 0.00% | – |
| Q2 2021 | $402,000 | +12.3% | 61,712 | +18.7% | 0.00% | – |
| Q1 2021 | $358,000 | -30.6% | 51,997 | +2.7% | 0.00% | – |
| Q4 2020 | $516,000 | +344.8% | 50,618 | +52.9% | 0.00% | – |
| Q3 2020 | $116,000 | -48.2% | 33,104 | -26.4% | 0.00% | – |
| Q2 2020 | $224,000 | – | 44,993 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |